AU2001281614A1 - Stabilization of immunogens derived from paramyxoviruses - Google Patents

Stabilization of immunogens derived from paramyxoviruses

Info

Publication number
AU2001281614A1
AU2001281614A1 AU2001281614A AU8161401A AU2001281614A1 AU 2001281614 A1 AU2001281614 A1 AU 2001281614A1 AU 2001281614 A AU2001281614 A AU 2001281614A AU 8161401 A AU8161401 A AU 8161401A AU 2001281614 A1 AU2001281614 A1 AU 2001281614A1
Authority
AU
Australia
Prior art keywords
paramyxoviruses
stabilization
immunogens derived
immunogens
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281614A
Inventor
Bruce Carpick
Bernard Cornet
Mathilde Luciani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
AVENTIS PASTEUR
Aventis Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AVENTIS PASTEUR, Aventis Pasteur Ltd filed Critical AVENTIS PASTEUR
Publication of AU2001281614A1 publication Critical patent/AU2001281614A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2001281614A 2000-08-07 2001-08-02 Stabilization of immunogens derived from paramyxoviruses Abandoned AU2001281614A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22342300P 2000-08-07 2000-08-07
US60/223,423 2000-08-07
PCT/CA2001/001108 WO2002012289A2 (en) 2000-08-07 2001-08-02 Stabilization of immunogens derived from paramyxoviruses

Publications (1)

Publication Number Publication Date
AU2001281614A1 true AU2001281614A1 (en) 2002-02-18

Family

ID=22836426

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281614A Abandoned AU2001281614A1 (en) 2000-08-07 2001-08-02 Stabilization of immunogens derived from paramyxoviruses

Country Status (4)

Country Link
US (1) US20040052800A1 (en)
AU (1) AU2001281614A1 (en)
CA (1) CA2418939A1 (en)
WO (1) WO2002012289A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4558652B2 (en) 2003-06-20 2010-10-06 マイクロビクス・バイオシステムズ・インコーポレイテツド Improved virus production
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW275632B (en) * 1992-04-21 1996-05-11 American Cyanamid Co
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
US6020162A (en) * 1997-06-13 2000-02-01 The Rockefeller University Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof
US6210683B1 (en) * 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
IL149778A0 (en) * 1999-11-22 2002-11-10 Universal Preservation Technologies Inc Preservation of sensitive biological material

Also Published As

Publication number Publication date
US20040052800A1 (en) 2004-03-18
WO2002012289A3 (en) 2002-09-19
WO2002012289A2 (en) 2002-02-14
CA2418939A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
GB2382346B (en) Method of synthesizing diketopiperazines
AU2002257663A1 (en) Stabilization of aroma-providing components
AU2001289085A1 (en) Antisense modulation of flip-c expression
MXPA03008547A (en) Stabilization of aroma-providing components.
AU2002345455A1 (en) Epoxide stabilization of fluorophosphite-metal catalyst system
AU2001263245A1 (en) Preparation of hydroxyalkylcarbamates from six-membered cyclic carbonates
AU2001227847A1 (en) Antisense modulation of pepck-cytosolic expression
AU2002366788A1 (en) Antisense modulation of ship-1 expression
AU2001266081A1 (en) Improvement of itraconazole bioavailability
AU4989400A (en) Stabilization of isothiazolone
AU2001245741A1 (en) Antisense inhibition of adam10 expression
AU2002357102A1 (en) Antisense modulation of cd36l1 expression
AU2001234462A1 (en) Antisense modulation of cot oncogene expression
AU2001281614A1 (en) Stabilization of immunogens derived from paramyxoviruses
EP1389249A4 (en) Retaining wall structure for soil stabilization
AU4152102A (en) Anti-inflammatory compounds derived from pseudopterogorgia elisabethae
AU2002322551A1 (en) Antisense modulation of rip2 expression
AU2001280292A1 (en) Formation stabilization
AU2001288908A1 (en) Antisense modulation of mekk3 expression
AU2002347809A1 (en) Antisense modulation of inhibitor-kappa b kinase-gamma expression
AU2002364169A1 (en) Dual inhibition of sister chromatide separation at metaphase
AU7512400A (en) Hardness stabilization by mercaptopyridines
AU2002245089A1 (en) Antisense modulation of cytohesin-1 expression
AU2002362757A1 (en) Antisense modulation of creb expression
AU2002243399A1 (en) Antisense modulation of raidd expression